MedTrace Logo

Effect of Enhanced Sweat Rate on the Safety and Edema Status of Chronic Edematous Patients

NCT04578353 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2023-11-01

No results posted yet for this study

Summary

The purpose of this study is to demonstrate safety and performance of AquaPass System for enhancing fluid transfer through the skin, by increased sweat rate, in edematous patients.

Conditions

Interventions

DEVICE

The AquaPass System

The AquaPass device is a capsule that creates relatively homogenous temperature around the patients' lower body, while controlling and maintaining at a low percentage the relative humidity within the capsule thus enabling controlled environment that enhances sweat rate.

Sponsors & Collaborators

  • AquaPass Medical Ltd.

    lead INDUSTRY

Principal Investigators

  • Doron Aronson, Professor · (Director, Inpatient Cardiology Unit (Rambam Health Care Campus)

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-01-28
Primary Completion
2022-02-12
Completion
2022-06-12

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04578353 on ClinicalTrials.gov